"Tele-health tactics gained momentum and our clients made their pivot, like other industries, to fully remote operations. RxS, with our technology-forward approach, was prepared for the shift."
PRESIDENT – US INFECTIOUS DISEASES & VACCINES, JANSSEN PHARMACEUTICALS
"In vaccines, we are progressing late-stage programs of break-through vaccines against diseases where vaccines are not currently available, such as RSV and multidrug resistant bacterial infections, including ExPEC and Staphylococcus aureus."
"Ultimately, we aim to fine-tune this foundational technology that can be applied to innumerable challenges across a variety of industries, making biology become more like software and programming."
GBR is pleased to release its Africa Energy 2025 report, following four months of interviews and research across Sub-Saharan Africa, during which time we met with over 120 companies, including those in the upstream, midstream, and downstream sectors, as well as governments, financiers, and service providers.